GUANGJI PHARMA's subsidiary has received the re-registration approval notice for Vitamin B6 chemical raw materials
GUANGJI PHARMA's subsidiary Hubei Huisheng Pharmaceutical Co., Ltd. recently received the re-registration approval notice for Vitamin B6 chemical raw materials issued by the Hubei Provincial Drug Administration. This batch ensures the stability and continuity of the production and sales qualifications for Vitamin B6
According to the Zhitong Finance APP, GUANGJI PHARMA (000952.SZ) announced that its controlling subsidiary, Hubei Huisheng Pharmaceutical Co., Ltd. (referred to as "Huisheng Company"), recently received the "Chemical Raw Material Drug Re-registration Approval Notice" approved and issued by the Hubei Provincial Drug Administration for the chemical raw material Vitamin B6.
Vitamin B6: The raw material is used for the production of Vitamin B6 tablets and Vitamin B6 injection. The acquisition of the above "Chemical Raw Material Drug Re-registration Approval Notice" ensures the stability and continuity of the production and sales qualifications for Vitamin B6
